Skip to content

STRYKER

Active
Public limited companyfounded 1996active for 30 yearsLeonardo da Vincilaan 19, 1831 Machelen (Brab.), BelgiumKBO/BCE: BE 0457.612.445
Summary

STRYKER has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5.8m and a net result of €2.6m. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 21% of 6,081 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
#7 company by staff growth in Machelen, Wholesale and retail trade sector1 site
Size
€61.1mturnover 2025
Staff
99.7 FTE
Equity
€5.8m
Profit
€2.6m
Financial health
84 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
STRYKER CORPORATION
Accounts 42 days early2 of 34 deeds read
Why 84raises riskLiquidity: current ratio 1.29, cash €413,177Equity €5.8m (19.3% of total assets)Sector: Wholesale trade (NACE 46)lowers riskLegal form: public limited companyShow the evidence

Checked score

Score 2025
84 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 34% of its sector peers (NACE 46, medium-sized)
Financial strength · tick = 2024
Weak
Solvency 44-47
equity 19.3% of total assets
Liquidity 11-28
short-term debt 75.6% · cash 1.4%
Profitability 67+7
return on assets 8.8%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (746 companies, NACE 46, medium-sized)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.3%▲ +0.2 percentage points vs 06-2026highest value 08-2026: 0.3%● unchanged vs 07-2026highest value 09-2026: 0.3%● unchanged vs 08-2026highest value 10-2026: 0.3%● unchanged vs 09-2026highest value
Credit of up to €480,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.29, compared with 3.39 in 2024; short-term debt: 75.6% and cash: 1.4% of total assets), and 80.7% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized): better than 24% on solvency, 11% on liquidity, 69% on profitability and 32% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 1.29, cash €413,177
NBB · annual accounts
raises risk · Equity €5.8m (19.3% of total assets)
NBB · annual accounts
lowers risk · Legal form: public limited company
KBO
raises risk · Sector: Wholesale trade (NACE 46)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 6081 sector peers (2025).
NBB · sector comparison
Position among 6081 sector peers
Solvency
better than 21%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-06-2026, 42 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
42 days early
2024
44 days early
2023
42 days early
2022
17 days early
2021
10 days late
2020
40 days early
2019
56 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
10-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Thomas Peer (director)Appointment: Tadhg Walsh (director) ·…
  2. Annual accounts filedfinancial year 2025 · full…
  3. Appointment: Tommaso Bareato (director)Gazette deed

Key points

  • Positive: Result rose in 2025from €992,087 to €2.6m ▲ 164% View
  • Positive: Among the best 9% on net resultsector median €113,523 · 6,022 companies €2.6m View
  • Board changedlatest change 01-09-2026 · 2 in office 2 joined · 1 left View
  • Controlled by STRYKER CORPORATION parent View
  • Positive: 7 profitable years in a rowprofit 2025: €2.6m 7 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Turnover
€61.1m
Profit
€2.6m
Solvency
19.3%
Turnover▲ 5.0%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
STRYKER CORPORATION
  • Tommaso BareatoDaily manager
  • Tadhg WalshDaily manager
Go to Board & ownership

Timeline

Events
34
Since
1997
Next accounts
by 31-07-2027
  1. 31-12-2025Highest result from 2018 to 2025
  2. 17-06-2025Annual accounts filed
  3. 19-06-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
28-03-1996
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.